The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients ...

Despite having a better safety profile, cold endoscopic mucosal resection led to a higher risk for recurrent/residual ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Colorectal cancer is the second leading cause of cancer death in the U.S., with over 152,000 cases and nearly 53,000 deaths ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

It’s worth thinking about when investigating the increase in colon cancer in young people.

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and ...

The rising rate of colon cancer in young people can't be caused by diet alone, doctors say. Microplastics, sleep, and antibiotics may play a role.

Colonoscopies play a vital role in detecting and preventing colorectal cancer, which is on the rise among young people.

The requirements for free colon cancer screenings would be relaxed from this year to include people aged 45 to 49, as well as ...

Regarding alcohol intake, they found a 15% higher risk of colorectal cancer for every 20 grams of alcohol consumed per day.